Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24359129)

1.

Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy.

Hsieh MC, Yeh PT, Yang CM, Yang CH.

J Ocul Pharmacol Ther. 2014 May;30(4):353-8. doi: 10.1089/jop.2013.0104. Epub 2013 Dec 21.

PMID:
24359129
2.

Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage.

Huang YH, Yeh PT, Chen MS, Yang CH, Yang CM.

Retina. 2009 Sep;29(8):1134-40. doi: 10.1097/IAE.0b013e3181b094b7.

PMID:
19672218
3.

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.

PMID:
20135139
4.

Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.

Yang CS, Hung KC, Huang YM, Hsu WM.

J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):550-5. doi: 10.1089/jop.2012.0202. Epub 2013 Mar 15.

5.

Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.

Sinawat S, Rattanapakorn T, Sanguansak T, Yospaiboon Y, Sinawat S.

Eye (Lond). 2013 Dec;27(12):1391-6. doi: 10.1038/eye.2013.200. Epub 2013 Sep 13.

6.

Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.

Sato T, Morita S, Bando H, Sato S, Ikeda T, Emi K.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):51-5. doi: 10.4103/0974-9233.106387.

7.

Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.

Yeh PT, Yang CH, Yang CM.

Acta Ophthalmol. 2011 Nov;89(7):634-40. doi: 10.1111/j.1755-3768.2009.01821.x. Epub 2010 Jan 8.

PMID:
20064118
8.

Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.

Ferenchak K, Duval R, Cohen JA, MacCumber MW.

Retina. 2014 Jun;34(6):1177-81. doi: 10.1097/IAE.0000000000000058.

PMID:
24457977
9.

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Park DH, Shin JP, Kim SY.

Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7. Epub 2009 Dec 12.

PMID:
20012643
10.

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.

Diabetic Retinopathy Clinical Research Network*.

JAMA Ophthalmol. 2013 Mar;131(3):283-93. doi: 10.1001/jamaophthalmol.2013.2015.

11.

Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.

Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R.

Ophthalmology. 2009 Oct;116(10):1943-8. doi: 10.1016/j.ophtha.2009.07.001. Epub 2009 Aug 21.

PMID:
19699531
12.

The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.

Ahn J, Woo SJ, Chung H, Park KH.

Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036. Epub 2011 Jul 2.

PMID:
21724263
13.

The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.

Göncü T, Özdek S, Ünlü M.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):88-93. doi: 10.5301/ejo.5000327. Epub 2013 Jun 17.

PMID:
23787453
14.

Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.

Gupta A, Bansal R, Gupta V, Dogra MR.

Int Ophthalmol. 2012 Apr;32(2):135-44. doi: 10.1007/s10792-012-9541-5. Epub 2012 Mar 27.

PMID:
22450558
15.

Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.

Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, Tano Y.

Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9.

PMID:
19269033
16.

Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.

Liu L, Wu WC, Yeung L, Wang NK, Kuo YH, Chao AN, Chen KJ, Chen TL, Lai CC, Hwang YS, Chen YP.

Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):72-7. doi: 10.3928/15428877-20091230-13.

PMID:
20128573
17.

Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.

Yang CM, Yeh PT, Yang CH, Chen MS.

Am J Ophthalmol. 2008 Aug;146(2):211-217. doi: 10.1016/j.ajo.2008.04.028. Epub 2008 Jun 11.

PMID:
18547539
18.

Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy.

Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1699-705. doi: 10.1007/s00417-008-0914-4. Epub 2008 Aug 12.

PMID:
18696095
19.

Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.

Neely KA, Scroggs MW, McCuen BW 2nd.

Am J Ophthalmol. 1998 Jul;126(1):82-90.

PMID:
9683153
20.

Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy.

Suzuki Y, Suzuki K, Yokoi Y, Miyagawa Y, Metoki T, Nakazawa M.

Retina. 2014 Jan;34(1):165-71. doi: 10.1097/IAE.0b013e3182979df6.

PMID:
23851630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk